CORSWO Model Stratifies Women According to Coronary Risk
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Dec. 13, 2024 -- The Coronary Risk Score in Women (CORSWO) can predict the risk of major adverse cardiovascular events (MACE), according to a study published online Dec. 5 in Radiology: Cardiothoracic Imaging.
Guillermo Romero-Farina, M.D., Ph.D., from Vall d'Hebron University Hospital in Barcelona, Spain, and colleagues conducted a retrospective analysis including 2,226 women from a cohort of 25,943 consecutive patients referred for clinical gated single-photon emission computed tomography myocardial perfusion imaging. The occurrence of MACE was assessed during a mean follow-up of 4 ± 2.7 years.
The researchers found that 148 of 1,460 women in the training group had MACE (2.6 percent per year). The best model to predict MACE in women had an area under the receiver operating characteristic curve (AUC) of 0.80 and included age older than 69 years, diabetes mellitus, pharmacologic test, ST-segment depression (≥1 mm), myocardial ischemia >5 percent, perfusion defect at rest >9 percent, perfusion defect at stress >6 percent, and end-systolic volume index >15 mL. The model achieved moderate performance during validation in 766 women (AUC, 0.78). CORSWO allowed for stratification into four risk levels: low, moderate, high, and very high. In women, the high and very-high risk levels predicted MACE, with excellent performance (AUC, 0.78).
"CORSWO is an effective tool to stratify the risk for MACE into four risk levels, including high and very-high risk, with good accuracy, although requiring multiple imaging variables," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-14 12:00
Read more
- Salmonella Outbreak Triggers Recall of Cucumbers in 26 States
- Teledermoscopy Accurate for Detecting Skin Cancers
- Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
- 2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence
- Optimal Timing of Maternal RSV Vaccine Determined to Be at Least Five Weeks Before Delivery
- FDA Approves Cobenfy for Adults With Schizophrenia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions